Toth Financial Advisory Corp Embecta Corp. Transaction History

Toth Financial Advisory Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$21.6 - $30.69 $2,095 - $2,976	97 Added 2425.0%	101 $2,000
Q1 2023 Apr 24, 2023	SELL	$23.07 - $32.77 $3,483 - $4,948	-151 Reduced 97.42%	4 $0
Q4 2022 Jan 24, 2023	SELL	$25.29 - $35.48 $8,345 - $11,708	-330 Reduced 68.04%	155 $0
Q3 2022 Oct 14, 2022	SELL	$24.0 - $33.42 $13,104 - $18,247	-546 Reduced 52.96%	485 $14,000
Q2 2022 Jul 25, 2022	BUY	$24.78 - $33.36 $25,548 - $34,394	1,031 New	1,031 $26,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.